Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Personalized Cell Therapy Market from 2025 to 2034, and What Factors Influence It?

The market size of personalized cell therapy has seen a substantial expansion recently. Its value is expected to escalate from $17.11 billion in 2024 to $21 billion in 2025, experiencing a compound annual growth rate (CAGR) of 22.8%. The significant progress noted in the past years is largely due to escalating understanding of personalized medicine, amplified healthcare expenditure, state-driven initiatives, increased financial backing for clinical studies, and a surge in neurological disorders.

Anticipated to experience remarkable growth in the coming years, the market for personalized cell therapy is set to increase to $47.14 billion in 2029, with a compound annual growth rate (CAGR) of 22.4%. Factors contributing to this predicted growth during the forecast period are an increase in clinical trials, a rising number of chronic disease cases, an ageing population, a growing prevalence of cancer, and enhanced adoption of regenerative medicines. The forecast period is also likely to see major trends such as advances in technology, implementation of AI, individualized vaccines, the rise of bioinformatics, and the introduction of microfluidic technologies.

What Combination of Drivers Is Leading to Accelerated Growth in the Personalized Cell Therapy Market?

Expectations are pointing towards the growth of the personalized cell therapy market due to the increasing incidence of neurological disorders. These disorders, which include symptoms like impaired motor function, cognitive deficits, and sensory disturbances, affect the brain, spinal cord, and nerves. Aging populations, lifestyle changes, and environmental stress factors are causing a surge in these neurodegenerative diseases. Personalized cell therapy offers a window of possibility for these conditions as it provides treatments curated for individual patients’ needs, possibly repairing damaged neural tissue and enhancing results for intricate, personalized disorders. In December 2022, the Parkinson Foundation, a US government organization, reported that the incidence of Parkinson’s disease among the elderly is 50% higher than the previously estimated 60,000 cases annually. They also predict an increase of 1.2 million Americans with Parkinson’s by 2030. Thus, the escalation in neurological disorders is propelling the growth of the personalized cell therapy market.

Explore Comprehensive Insights Into The Global Personalized Cell Therapy Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19137&type=smp

Who Are the Leading Players Fueling Growth in the Personalized Cell Therapy Market?

Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.

What Are the Emerging Trends Shaping the Future of the Personalized Cell Therapy Market?

Prominent corporations in the personalized cell therapy market are concentrating on establishing strategic alliances to expedite the progression and introduction of novel therapies. These partnerships allow businesses to combine their resources, skills, and technologies to improve research and development competencies, streamline clinical tests, and effectively handle regulatory pathways. For example, Century Therapeutics Inc., an American biotech firm, allied with Bristol Myers Squibb (BMS), a US biopharmaceutical corporation, in October 2022, to foster and bring to market allogeneic cell therapies. The partnership leverages Century’s groundbreaking induced pluripotent stem cell (iPSC) methodology to fabricate engineered natural killer (NK) and T cell therapies to address hematologic malignancies and solid tumors. The pact includes the cultivation of up to four separate cell therapy initiatives, primarily concentrating on two particular domains: acute myeloid leukemia (AML) and multiple myeloma. These initiatives will employ engineered NK cells or gamma delta T cells sourced from iPSCs.

Secure Your Global Personalized Cell Therapy Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/personalized-cell-therapy-global-market-report

Which Key Segments Define the Structure of the Personalized Cell Therapy Market and Their Growth Potential?

The personalized cell therapymarket covered in this report is segmented –

1) By Cell Type: Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type

2) By Technique: Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation

3) By Application: Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications

4) By End-User: Hospital, Homecare, Specialty Clinics, Other End-User

Subsegments:

1) By Lymphocytes: T Cells, Natural Killer (NK) Cells, Regulatory T Cells

2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs, Adipose Tissue-Derived MSCs, Umbilical Cord-Derived MSCs

3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells, Allogeneic Hematopoietic Stem Cells

4) By Other Cell Types: Dendritic Cells, Fibroblasts, Endothelial Cells

Which Regions Are Driving Growth in the Personalized Cell Therapy Market?

North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Personalized Cell Therapy Market Defined Across Different Regions?

Personalized cell therapy refers to a type of medical treatment where a patient’s own cells, or cells that are specifically tailored to them, are used to treat a disease or condition. This therapy is customized to the individual’s unique biological profile, often involving the modification or manipulation of cells to enhance their therapeutic potential. The key advantage of personalized cell therapy is that it minimizes the risk of rejection and adverse reactions as the therapy is designed to be compatible with the patient’s own body.

Browse Through More Similar Reports By The Business Research Company:

Cell Therapy Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Personalized Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: